Capital Menu
Founder funding
$0‑??
Idea → Prototype
0%
Instant
100% control
$250k‑$10M
Pre‑clinical → Clinical/Pilot
0–low
2‑6 mo
Mission‑aligned investment arms (often foundation‑ or patient‑community–backed; e.g., CFF, JDRF T1D Fund, RD Fund, MMRF)
$100k‑$5M
Pilot → Pivotal study
0–low
2‑6 mo
Funds RCTs, biomarkers, device‑drug combos
$100k‑10M
Prototype → Pilot
0%
Deal cycle
De‑risks demand; customer skin‑in‑game
Any
Post‑reg clearance / launch
0%
Market‑driven
Cheapest money available, clearest market signal – (almost) always your best option.
$2‑3M
MVP → Early growth
15‑20%
2‑4+ mo
Board seat, prefs – be careful: might be point of no return!
$1‑15M
After ≥$3M equity & 12 mo runway
<1% warrants
4‑6 wk
Be very, very careful here. Covenants can kill companies quick.
Up to mid‑7 figures
Growth / community raise
High (retail cap table + fees)
2‑6 mo
Community and brand aligned; disclosure and investor‑relations burden
Varies
Post‑PMF → Growth
Dilutive or profit‑sharing
3‑12 mo
Aligns team/community via ESOPs, co‑ops, or SPVs; governance and admin complexity
Varies
Post‑pilot → Growth
Governance trade‑offs, no equity
2‑6 mo
Mission‑lock IP; global access clauses
Click on any funding type above to jump to its detailed deep dive. Deep‑dive sections map to these families: Non‑dilutive / Philanthropic, Government & Multilateral, Mission‑Aligned Investors, Equity Capital Spectrum, Structured & Hybrid Equity, Credit & Debt, Capital‑Markets‑Lite & Crowd, Corporate & Strategic, Employee & Community Ownership.
For detailed information on each funding type, see the Capital Menu Deep Dives section. Also see Capital from Customers for non‑dilutive customer capital strategies.
Last updated
